Dr. Galvin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
840 S Wood St
Suite 130 CSN
Chicago, IL 60612
Summary
- Dr. John Galvin is a hematologist with a specialization in stem-cell transplant and GVHD based in Chicago, IL. Dr. Galvin is affiliated with University of Illinois Cancer Center. Dr. Galvin is also a Senior Medical Director for Graft versus Host Disease for Incyte Pharmaceuticals. He has been in practice 11 years. He also has an affiliation with Northwestern University’s department of Immunology & Microbiology.
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Hematopoietic Stem Cell Transplant, 2012 - 2013- McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2009 - 2012
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 2006 - 2009
University of Illinois College of MedicineClass of 2006
Certifications & Licensure
IL State Medical License 2009 - 2026
NY State Medical License 2008 - 2010- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Clinical Trials
- Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients Start of enrollment: 2013 Jul 19
- Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease Start of enrollment: 2016 Aug 01
- Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia Start of enrollment: 2014 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsAmphiregulin as a biomarker for monitoring lifethreatening acute graft--host disease: secondary analysis of two prospective clinical trials.Shernan G Holtan, Najla El Jurdi, Armin Rashidi, Brian C Betts, Connor Demorest
Haematologica. 2024-05-01 - 6 citationsImpact of Chronic Graft-versus-Host Disease on Patient Employment, Income, and Informal Caregiver Burden: Findings From the Living With Chronic GVHD Patient Survey.Jingbo Yu, Nandita Khera, James Turnbull, Susan K Stewart, Paul Williams
Transplantation and Cellular Therapy. 2023-07-01 - Correction to: Disease progression, treatments, hospitalization, and clinical outcomes in acute GVHD: a multicenter chart review.Shernan G Holtan, Jingbo Yu, Hannah K Choe, Dilan Paranagama, Jackson Tang
Bone Marrow Transplantation. 2023-02-01
Abstracts/Posters
- Development of a Real Time Pharmacokinetic Testing Method to Allow for Targeted Melphalan Dosing in Multiple Myeloma Patients Undergoing Autologous TransplantJohn P Galvin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Low Pre-Treatment Hemoglobin and Creatinine Clearance Correlate with Worse Overall Survival, Treatment-Related Mortality, and Regimen-Related Toxicities in Patients Un...John P Galvin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Disease Progression, Hospital Readmissions, and Clinical Outcomes of Patients with Steroid-Refractory Acute Graft-Versus-Host Disease: A Multicenter Chart ReviewJohn P Galvin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Searching for lymphoma: An analysis of internet and social network activity and engagement.2019 ASCO Annual Meeting - 6/1/2019
- Survival Differences Among Patients (pts) with Acute Myeloid Leukemia (AML) Treated with Allogeneic Hematopoietic Cell Transplantation (HCT) Versus Non-HCT Therapies: ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Use of a Processed Hematopoietic Stem Cell Product (FCRx) in Unmatched Related and Unrelated Donor – Recipient Pairs Is Associated with High Levels of Donor Chimerism ...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
Study Shows Structural Racism Can Result in Poorer Leukemia OutcomesMarch 7th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
